Clinical Trials on Resectable MMR-deficient Solid Tumors in United Kingdom
Total 3328 results
-
Albert Einstein College of MedicineTerminatedCancer | Solid Tumor | Metastatic Solid Tumor | Metastatic dMMR Solid CancerUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, China, Spain, Japan, United Kingdom
-
Andes BiotechnologiesTerminatedAdvanced Unresectable Solid TumorsUnited States
-
Fore BiotherapeuticsActive, not recruitingAdvanced Unresectable Solid Tumors | BRAF-mutated TumorsUnited States
-
National Cancer Institute (NCI)RecruitingSolid Tumor | Refractory Solid Tumors | Malignant Solid Tumors | Other Neoplasms Solid Tumors | Pediatric Solid TumorUnited States
-
Agalimmune Ltd.CompletedSuperficial, Palpable, Unresectable/Metastatic Solid TumourUnited States, Israel, United Kingdom
-
Incyte CorporationCompletedUnresectable or Metastatic Solid TumorsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyRecruitingMetastatic or Locally Advanced Unresectable Solid TumorsUnited States, Canada, Spain
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsCompletedMetastatic or Unresectable Solid Tumor MalignancyUnited States
-
Syndax PharmaceuticalsCompletedSolid Tumor | Unresectable Malignant Neoplasm | Locally Advanced Malignant Neoplasm | Metastatic TumorUnited States
-
Frontier Medicines CorporationRecruitingColorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Unresectable Solid Tumor | KRAS G12C | Advanced Solid Tumors With KRAS G12C MutationsUnited States
-
Ikena OncologyRecruitingSolid Tumor | Solid Tumors, Adult | Malignant Pleural Mesothelioma (MPM) | Epithelioid Hemangioendothelioma (EHE) | NF2 Deficient Mesothelioma | Other NF2 Deficient Solid Tumors and Solid Tumors With YAP1/TAZ Fusion Genes | NF2 Deficiency | YAP1 or TAZ Gene FusionsUnited States, United Kingdom
-
Massachusetts General HospitalBoehringer Ingelheim; Incyte CorporationRecruitingCholangiocarcinoma | Advanced Solid Tumor | Metastatic Solid Tumor | Unresectable Solid TumorUnited States
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.; Simcere ZaimingRecruitingLocally Advanced Unresectable or Metastatic Solid TumorUnited States, China
-
AstraZenecaParexelTerminatedAdvanced Solid TumorsUnited Kingdom
-
AstraZenecaCompletedAdvanced Solid Metastatic TumorUnited Kingdom
-
Immatics US, Inc.CompletedCancer | Solid Tumor | Refractory Solid Tumors | Recurrent Solid TumorsUnited States, Germany
-
Chugai Pharma Europe Ltd.CompletedSolid TumorsUnited Kingdom
-
Mateon TherapeuticsCancer Research UKCompleted
-
BeiGeneCompletedAdvanced Solid TumorsUnited Kingdom
-
Blueprint Medicines CorporationCompletedGastrointestinal Stromal Tumors | GIST | Non-resectable Advanced Solid Tumors | Recurrent or Unresectable Central Nervous System (CNS) TumorsUnited States
-
Novartis PharmaceuticalsRecruitingRare Unresectable or Metastatic BRAF V600E Mutation-positive Solid TumorsUnited States
-
AstraZenecaCompletedRefractory Solid Tumors | Cancer TumorUnited States
-
Eisai LimitedCompleted
-
CytomX TherapeuticsTerminatedSolid Tumor | Unresectable or Metastatic MelanomaKorea, Republic of, United States, Netherlands, Spain, Australia
-
National Cancer Institute (NCI)CompletedAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Recurrent Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Ovarian Carcinoma | Pancreatic Neuroendocrine Tumor | Unresectable Solid Neoplasm | Fibrolamellar CarcinomaUnited States
-
AstraZenecaCompleted
-
AstraZenecaKuDOS Pharmaceuticals LimitedCompletedMalignant Solid TumorsUnited Kingdom
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; Onyx Therapeutics, Inc.Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedCancer, Advanced Solid TumorsUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterAstraZenecaRecruitingSolid Tumor | Metastatic Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Solid Carcinoma | Metastatic TumorUnited States
-
PharmaMarCompletedAdvanced Solid TumorsUnited Kingdom, Switzerland
-
Genentech, Inc.CompletedSolid TumorUnited Kingdom
-
West Cancer CenterRecruitingHomologous Recombination Deficient Solid TumorsUnited States
-
Basilea PharmaceuticaCompletedSolid Organ TumorsUnited Kingdom
-
Queen Mary University of LondonRecruiting
-
PharmaMarCompletedSpecific Advanced Solid TumorsSpain, United Kingdom
-
Georgetown UniversityImmune System Key LtdRecruitingSolid Tumor | KRAS Mutation-Related TumorsUnited States
-
AstraZenecaActive, not recruitingSolid TumorsUnited Kingdom, Canada
-
LondonPharma Ltd.Unknown
-
Nerviano Medical SciencesTerminatedAdvanced/Metastatic Solid TumorsUnited Kingdom, France
-
Leucid BioRecruitingTumor, SolidUnited Kingdom
-
University College, LondonImperial College London; Cancer Research UK; National Cancer Imaging Translational...RecruitingCancer | Tumor, SolidUnited Kingdom
-
Cancer Research UKCompleted
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
AstraZenecaCompletedSolid TumorsUnited States, France, United Kingdom
-
AstraZenecaRecruitingAdvanced Solid Tumours That Are MTAP DeficientUnited States, Spain, Korea, Republic of, Australia, Japan, China, Netherlands, France
-
LondonPharma Ltd.UnknownSolid TumoursUnited Kingdom